Large-scale Profiling of ADP-Ribosylome by Chemical Proteomics
Ontology highlight
ABSTRACT: We have developed a dual metabolic incorporation of clickable NAD precursor compounds in live mammalian cells and in combination with the tandem mass tag (TMT) isobaric mass spectrometry, we have quantified the responses of thousands of endogenous proteins to clinical PARP inhibitors Olaparib and Rucaparib.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Permanent Cell Line Cell, Cell Culture
DISEASE(S): Breast Cancer
SUBMITTER: Kalesh Karunakaran
LAB HEAD: Peter A. DiMaggio
PROVIDER: PXD011631 | Pride | 2019-05-01
REPOSITORIES: Pride
ACCESS DATA